Elevated serum CA 19‐9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation

78Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hepatobiliary cystadenomas with mesenchymal stroma (CMS) are rare tumors. Two cases are reported that illustrate many features of CMS, including polypoid involvement of the common hepatic duct in one case. Both tumors were associated with elevated serum levels of the tumor‐associated antigen CA 19‐9 but normal levels of carcinoembryonic antigen and alpha‐fetoprotein. Immunohistochemical analysis confirmed the presence of CA 19‐9 in the epithelial component of the tumor. The implications of these findings are discussed, both in relation to the histogenesis of CMS and its preoperative diagnosis. A minimally elevated level of CA 19‐9 was found in only one of five patients with hydatid disease of the liver, an important differential diagnosis in clinical management. Cancer 1992; 70:1841–1846. Copyright © 1992 American Cancer Society

Cite

CITATION STYLE

APA

Thomas, J. A., Scriven, M. W., Puntis, M. C. A., Jasani, B., & Williams, G. T. (1992). Elevated serum CA 19‐9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation. Cancer, 70(7), 1841–1846. https://doi.org/10.1002/1097-0142(19921001)70:7<1841::AID-CNCR2820700706>3.0.CO;2-X

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free